NCT03792659 The EXPLORE MG Registry for Myasthenia Gravis
| NCT ID | NCT03792659 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Myasthenia Gravis |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2016-03-30 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2016-03-30 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
Eligibility Criteria
Inclusion Criteria: * Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data. Exclusion Criteria: * Failure to meet the Inclusion Criteria.
Contact & Investigator
Richard Nowak, MD, MS
PRINCIPAL INVESTIGATOR
Assistant Professor, Yale University
Frequently Asked Questions
Who can join the NCT03792659 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Myasthenia Gravis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03792659 currently recruiting?
Yes, NCT03792659 is actively recruiting participants. Contact the research team at bailey.munrosheldon@yale.edu for enrollment information.
Where is the NCT03792659 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT03792659 clinical trial?
NCT03792659 is sponsored by Yale University. The principal investigator is Richard Nowak, MD, MS at Assistant Professor, Yale University. The trial plans to enroll 800 participants.